Rifaximin


( Last Updated : August 5, 2014)
Generic Name:
Rifaximin
Project Status:
Complete
Therapeutic Area:
Hepatic encephalopathy
Manufacturer:
Salix Pharmaceuticals Inc.
Call for patient/clinician input open:
Brand Name:
Zaxine
Project Line:
Reimbursement Review
Project Number:
SR0388-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Encephalopathy, Hepatic
Recommendation Type:
List with criteria/condition
Final Recommendation: